PEG-IFN lambda: Phase IIb data

Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Product: PEG-IFN lambda (peginterferon lambda) ( PEG-rIL-29) Business: Infectious Molecular target: Interleukin-29 (IL-29) (IFNL1) Description: Pe...